Ultragenyx Pharmaceutical Inc.RARENASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank86
3Y CAGR+13.0%
5Y CAGR+13.2%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+13.0%/yr
Annual compound
5Y CAGR
+13.2%/yr
Consistent
Percentile
P86
Within normal range
vs 5Y Ago
1.9x
Solid growth
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $62.00M | -1.7% |
| 2024 | $63.04M | -4.5% |
| 2023 | $66.00M | +53.4% |
| 2022 | $43.02M | +46.2% |
| 2021 | $29.42M | -11.6% |
| 2020 | $33.29M | +2833.1% |
| 2019 | $1.14M | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |